Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases

NCT07595094 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Nanchang University as lead sponsor.

NCT NCT07595094
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07595094 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phenotypic Age Acceleration (PhenoAgeAccel) for Joint Prediction of Disease Risk, Mortality Risk, Life Expectancy, and Disease-Free Healthspan in Major Chronic Diseases
Lead sponsor
Second Affiliated Hospital of Nanchang University
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2006
Completion date
June 30, 2030
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biological aging marker, chinese population, disease risk prediction, disease-free healthspan, life expectancy, mortality risk prediction, observational cohort study, phenotypic age acceleration